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Disseminated fusariosis
Figure 1. Disseminated fusariosis with skin (A, B), lung (C) and trachea (D) localization.
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j idA 62-year-old man was diagnosed with mixed phenotype acute
leukemia, T/myeloid, not otherwise speciﬁed. He received induc-
tion chemotherapy with idarubicin and cytarabine, followed by
intermediate-dose cytarabine and amsacrine (consolidation). At
day 15 of consolidation therapy, when he was severely neutrope-
nic, he developed a fever and disseminated skin lesions that were
randomly scattered over his face, trunk and extremities. These
consisted of numerous circumscribed erythematous nodules,
frequently with central necrosis and ulceration (Figure 1A).http://dx.doi.org/10.1016/j.ijid.2014.11.022
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Cultures of skin tissue and blood revealed Fusarium solani. A skin
biopsy demonstrated angioinvasive fungus in the dermis
(Figure 1B, periodic acid-Schiff staining). The patient was treated
with a combination of liposomal amphotericin B and voriconazole.
His clinical condition rapidly deteriorated and he developed
progressive respiratory failure due to fusarial pneumonia. Ulti-
mately the patient died. Post-mortem examination demonstrated
a disseminated invasive fusariosis with skin, eye, lung (Figure 1C)
and trachea (Figure 1D) localization.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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